ArticleFrontiers in immunology2025
Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.
Lu Zou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it